Showing results (41-50 of 47) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 1995
Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigenK A Foon, A R Oseroff, L Vaickus, et al.Journal of Medicinal Chemistry|July 6, 2000
Water-soluble, core-modified porphyrins as novel, longer-wavelength-absorbing sensitizers for photodynamic therapyC E Stilts, M I Nelen, D G Hilmey, et al.Leukemia|April 1, 1997
Pleiotropic expression of heterologous cytokine/receptor genes in HTLV-1 associated diseases: candidate TRS for chimeric gene therapyS J Greenberg, U Choi, P M Overturf, et al.Journal of Medicinal Chemistry|November 23, 2000
A selenopyrylium photosensitizer for photodynamic therapy related in structure to the antitumor agent AA1 with potent in vivo activity and no long-term skin photosensitizationK A Leonard, J P Hall, M I Nelen, et al.Journal of Medicinal Chemistry|October 3, 1999
Synthesis and evaluation of chalcogenopyrylium dyes as potential sensitizers for the photodynamic therapy of cancerK A Leonard, M I Nelen, T P Simard, et al.AIDS (London, England)|October 6, 1999
Photofrin photodynamic therapy for treatment of AIDS-related cutaneous Kaposi's sarcomaZ P Bernstein, B D Wilson, A R Oseroff, et al.Cancer Research|February 17, 2000
Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rateB W Henderson, T M Busch, L A Vaughan, et al.Pageof 5